177 related articles for article (PubMed ID: 28401485)
1. Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade.
Choi ES; Oh S; Jang B; Yu HJ; Shin JA; Cho NP; Yang IH; Won DH; Kwon HJ; Hong SD; Cho SD
Cell Oncol (Dordr); 2017 Jun; 40(3):235-246. PubMed ID: 28401485
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferative and apoptotic effects of silibinin in rat prostate cancer cells.
Tyagi A; Bhatia N; Condon MS; Bosland MC; Agarwal C; Agarwal R
Prostate; 2002 Nov; 53(3):211-7. PubMed ID: 12386921
[TBL] [Abstract][Full Text] [Related]
3. Silymarin inhibits growth and causes regression of established skin tumors in SENCAR mice via modulation of mitogen-activated protein kinases and induction of apoptosis.
Singh RP; Tyagi AK; Zhao J; Agarwal R
Carcinogenesis; 2002 Mar; 23(3):499-510. PubMed ID: 11895866
[TBL] [Abstract][Full Text] [Related]
4. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
[TBL] [Abstract][Full Text] [Related]
5. Targeting ERK1/2-bim signaling cascades by BH3-mimetic ABT-737 as an alternative therapeutic strategy for oral cancer.
Shin JA; Kim LH; Lee SJ; Jeong JH; Jung JY; Lee HN; Hong IS; Cho SD
Oncotarget; 2015 Nov; 6(34):35667-83. PubMed ID: 26447615
[TBL] [Abstract][Full Text] [Related]
6. Flavonoid, silibinin, inhibits proliferation and promotes cell-cycle arrest of human colon cancer.
Hogan FS; Krishnegowda NK; Mikhailova M; Kahlenberg MS
J Surg Res; 2007 Nov; 143(1):58-65. PubMed ID: 17950073
[TBL] [Abstract][Full Text] [Related]
7. Silibinin induces cell death through reactive oxygen species-dependent downregulation of notch-1/ERK/Akt signaling in human breast cancer cells.
Kim TH; Woo JS; Kim YK; Kim KH
J Pharmacol Exp Ther; 2014 May; 349(2):268-78. PubMed ID: 24472723
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer prevention by silibinin.
Singh RP; Agarwal R
Curr Cancer Drug Targets; 2004 Feb; 4(1):1-11. PubMed ID: 14965263
[TBL] [Abstract][Full Text] [Related]
9. Comparative Evaluation of Silibinin Effects on Cell Cycling and Apoptosis in Human Breast Cancer MCF-7 and T47D Cell Lines.
Jahanafrooz Z; Motameh N; Bakhshandeh B
Asian Pac J Cancer Prev; 2016; 17(5):2661-5. PubMed ID: 27268647
[TBL] [Abstract][Full Text] [Related]
10. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
11. Silibinin induces apoptosis of HT29 colon carcinoma cells through early growth response-1 (EGR-1)-mediated non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) up-regulation.
Woo SM; Min KJ; Kim S; Park JW; Kim DE; Chun KS; Kim YH; Lee TJ; Kim SH; Choi YH; Chang JS; Kwon TK
Chem Biol Interact; 2014 Mar; 211():36-43. PubMed ID: 24440808
[TBL] [Abstract][Full Text] [Related]
12. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages.
Tyagi A; Agarwal C; Harrison G; Glode LM; Agarwal R
Carcinogenesis; 2004 Sep; 25(9):1711-20. PubMed ID: 15117815
[TBL] [Abstract][Full Text] [Related]
13. Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy.
Molavi O; Narimani F; Asiaee F; Sharifi S; Tarhriz V; Shayanfar A; Hejazi M; Lai R
Pharm Biol; 2017 Dec; 55(1):729-739. PubMed ID: 28027688
[TBL] [Abstract][Full Text] [Related]
14. Silibinin triggers apoptotic signaling pathways and autophagic survival response in human colon adenocarcinoma cells and their derived metastatic cells.
Kauntz H; Bousserouel S; Gossé F; Raul F
Apoptosis; 2011 Oct; 16(10):1042-53. PubMed ID: 21779837
[TBL] [Abstract][Full Text] [Related]
15. Combination of HDAC inhibitor TSA and silibinin induces cell cycle arrest and apoptosis by targeting survivin and cyclinB1/Cdk1 in pancreatic cancer cells.
Feng W; Cai D; Zhang B; Lou G; Zou X
Biomed Pharmacother; 2015 Aug; 74():257-64. PubMed ID: 26349994
[TBL] [Abstract][Full Text] [Related]
16. Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation.
Tilley C; Deep G; Agarwal C; Wempe MF; Biedermann D; Valentová K; Kren V; Agarwal R
Mol Carcinog; 2016 Jan; 55(1):3-14. PubMed ID: 25492239
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation and nuclear localization of survivin by sodium butyrate induces caspase-dependent apoptosis in human oral mucoepidermoid carcinoma.
Jang B; Yang IH; Cho NP; Jin B; Lee W; Jung YC; Hong SD; Shin JA; Cho SD
Oral Oncol; 2019 Jan; 88():160-167. PubMed ID: 30616788
[TBL] [Abstract][Full Text] [Related]
18. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells.
Kauntz H; Bousserouel S; Gossé F; Raul F
Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452
[TBL] [Abstract][Full Text] [Related]
19. Influence of silibinin and β-β-dimethylacrylshikonin on chordoma cells.
Jahanafrooz Z; Stallinger A; Anders I; Kleinegger F; Lohberger B; Durchschein C; Bauer R; Deutsch A; Rinner B; Kretschmer N
Phytomedicine; 2018 Oct; 49():32-40. PubMed ID: 30217260
[TBL] [Abstract][Full Text] [Related]
20. Synergistic apoptotic effects of silibinin in enhancing paclitaxel toxicity in human gastric cancer cell lines.
Zhang Y; Ge Y; Ping X; Yu M; Lou D; Shi W
Mol Med Rep; 2018 Aug; 18(2):1835-1841. PubMed ID: 29901126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]